Summary
The effect of isosorbide-dinitrate (ISDN) 20 mg 4 times daily against placebo has been tested in 12 patients with stable effortinduced angina pectoris receiving prophylactic treatment with metoprolol. ISDN did not decrease the attack rate or nitroglycerine consumption, nor was exercise tolerance increased after it. Left ventricular function, assessed by radionucleide ventriculography, increased in 6 out of 8 patients (p<0.1). It is concluded that ISDN has no place in the treatment of haemodynamically intact patients with severe angina pectoris in spite of beta-blocking treatment, but that it may be of value in the treatment of patients with left ventricular failure, including those whose left ventricular failure has been brought about by beta-blocking treatment necessitated by angina pectoris.
Similar content being viewed by others
References
Klaus AP, Zaret BL, Pitt BL, Ross RS (1973) Comparative evaluation of sublingual long-acting nitrates. Circulation 48: 519–525
Russek HI (1968) Propranolol and isosorbide dinitrate synergism in angina pectoris. Am J Cardiol 21: 44–54
Baxter RH, Lennox IM (1977) Increased exercise tolerance with nitrates in beta-blockaded patients with angina. Br Med J 2: 550–552
Storstein L (1981) The effect of pindolol and isosorbide dinitrate and their combination on exercise tolerance and ECG changes in angina pectoris. Acta Med Scand 209: 357–362
Battock DJ, Alvarez H, Chidsey CA (1969) Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic activity in patients with angina pectoris. Circulation 44: 157–169
Aronow WS, Kaplan MA (1969) Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. N Engl J Med 280: 847–850
Goldberg AN, Moran JF, Butterfield TK, Nemickas R, Bermudez GA (1969) Therapy of angina pectoris with propranolol and long-acting nitrates. Circulation 40: 847–853
Taylor T, O'Kelly DA, Major RM, Darvagh A, Chasseaud LF (1978) Plasma concentrations of isosorbide dinitrates after administration of increasing doses of a sustained-release formulation to human subjects. Drug Res 28 (II): 1426–1428
Thadani U, Fung H-L, Darke AC, Parker JO (1980) Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation 62: 491–502
Brogden RN, Heel RC, Speight Tm, Averylis (1977) Metoprolol: A review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drug 14: 321–348
Muir AL, Hannan WJ, Sapru RP, Boardman AK, Wraith PK, Brash HM (1980) The effect of isorenaline, atropine and dobutamine on ventricular volume curves obtained by radionucleide ventriculography. Clin Sci 58: 357–364
Ritchie JL, Sorensen SG, Kennedy JW, Hamilton GW (1979) Radionucleide angiography non-invasive assessment of haemodynamic changes after administration of nitroglycerine. Am J Cardiol 43: 278–284
Sweatman T, Strauss G, Selzer A, Cohn KE (1972) The long-acting haemodynamic effects of isosorbide dinitrate. Am J Cardiol 29: 475–480
Williams DO, Bommer WJ, Miller RR, Amsterdam EA, Mason DT (1977) Haemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure. Prolonged effectiveness of isosorbide dinitrate. Am J Cardiol 39: 84–90
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jensen, G., Trautner, F., Rasmussen, S. et al. Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment. Eur J Clin Pharmacol 24, 169–172 (1983). https://doi.org/10.1007/BF00613812
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613812